Lincoln Pharmaceuticals Ltd.
LINCOLN Share PricePharmaceuticals & Drugs
₹560.15
1.4 (0.3%)
As on September 8, 2025
Exchange Scrips: BSE531633NSELINCOLNISININE405C01035
Market Cap ₹ 1,114 Cr
P/E Ratio 12.02
Dividend Yield 0.03 %
Performance
Market performance
Open552
High565.75
Volumes17,737
Prev560.15
Low552
As on2025-09-08
Historical performance
1 Year High979.5
3 Year High979.5
5 Year High979.5
1 Year Low499
3 Year Low275.05
5 Year Low206
Fundamentals
Company Valuation
Market Cap (₹Cr)
1,114
Face Value (₹)
10
P/E Ratio
12.02
Dividend Yield
0.03 %
Investment Returns
1 Year
-27.5%
3 Years
93%
5 Years
137.9%
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 556.08 | Bullish |
| 10-DMA | 549.24 | Bullish |
| 20-DMA | 549.9 | Bullish |
| 50-DMA | 552.29 | Bullish |
| 100-DMA | 562.29 | Bearish |
| 200-DMA | 624.86 | Bearish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 25 | 25 | 25 | 25 | 25 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 25 | 25 | 25 | 25 | 25 |
| Public Investors | 31759 | 31842 | 31823 | 31305 | 29942 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 12.02.
- 3Y Stock Price CAGR of the stock is 25.0.
- The stock has a beta of 1.1.
- In the last financial year, the company had an EBITDA of ₹1343 Million.
- The company generated revenue of ₹5806 Million in the previous financial year.
Lincoln Pharmaceuticals Ltd.
560.151.4 (0.3%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 726006.1
No. of Shares: 1296 (Approx)
Performance:-27.4%
P/L: ₹-273993.9
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent